These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7538873

  • 1. Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats.
    Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR.
    Brain Res Bull; 1995; 36(6):549-56. PubMed ID: 7538873
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
    [Abstract] [Full Text] [Related]

  • 3. Intrastriatal 3-nitropropionic acid: a behavioral assessment.
    Koutouzis TK, Borlongan CV, Freeman TB, Cahill DW, Sanberg PR.
    Neuroreport; 1994 Nov 21; 5(17):2241-5. PubMed ID: 7881036
    [Abstract] [Full Text] [Related]

  • 4. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E.
    Neuroscience; 1997 Jul 21; 79(1):45-56. PubMed ID: 9178864
    [Abstract] [Full Text] [Related]

  • 5. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
    Vis JC, Verbeek MM, De Waal RM, Ten Donkelaar HJ, Kremer HP.
    Neuropathol Appl Neurobiol; 1999 Dec 21; 25(6):513-21. PubMed ID: 10632901
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
    Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT.
    J Neurosci; 1993 Oct 21; 13(10):4181-92. PubMed ID: 7692009
    [Abstract] [Full Text] [Related]

  • 7. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y, Chu SF, Li JP, Zhang Z, Yan JQ, Wen ZL, Xia CY, Mou Z, Wang ZZ, He WB, Guo XF, Wei GN, Chen NH.
    Acta Pharmacol Sin; 2015 Mar 21; 36(3):311-22. PubMed ID: 25640478
    [Abstract] [Full Text] [Related]

  • 8. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
    Garcia M, Vanhoutte P, Pages C, Besson MJ, Brouillet E, Caboche J.
    J Neurosci; 2002 Mar 15; 22(6):2174-84. PubMed ID: 11896157
    [Abstract] [Full Text] [Related]

  • 9. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    Reynolds DS, Carter RJ, Morton AJ.
    J Neurosci; 1998 Dec 01; 18(23):10116-27. PubMed ID: 9822765
    [Abstract] [Full Text] [Related]

  • 10. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration.
    Fernagut PO, Diguet E, Bioulac B, Tison F.
    Exp Neurol; 2004 Jan 01; 185(1):47-62. PubMed ID: 14697318
    [Abstract] [Full Text] [Related]

  • 11. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease.
    Chakraborty J, Nthenge-Ngumbau DN, Rajamma U, Mohanakumar KP.
    Behav Brain Res; 2014 May 01; 264():91-104. PubMed ID: 24509309
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
    McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH.
    Exp Neurol; 2003 Jun 01; 181(2):213-23. PubMed ID: 12781994
    [Abstract] [Full Text] [Related]

  • 13. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN, Sumathi T.
    Metab Brain Dis; 2017 Apr 01; 32(2):471-481. PubMed ID: 27928694
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Systemic 3-nitropropionic acid: long-term effects on locomotor behavior.
    Koutouzis TK, Borlongan CV, Scorcia T, Creese I, Cahill DW, Freeman TB, Sanberg PR.
    Brain Res; 1994 May 23; 646(2):242-6. PubMed ID: 8069670
    [Abstract] [Full Text] [Related]

  • 17. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.
    Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP.
    CNS Neurosci Ther; 2014 Jan 23; 20(1):10-9. PubMed ID: 24188794
    [Abstract] [Full Text] [Related]

  • 18. The 3-NP Model of Striatal Neurodegeneration.
    Brouillet E.
    Curr Protoc Neurosci; 2014 Apr 10; 67():9.48.1-9.48.14. PubMed ID: 24723322
    [Abstract] [Full Text] [Related]

  • 19. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease.
    Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR.
    Brain Res; 1995 Oct 30; 697(1-2):254-7. PubMed ID: 8593585
    [Abstract] [Full Text] [Related]

  • 20. The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.
    Vis JC, Verbeek MM, de Waal RM, ten Donkelaar HJ, Kremer B.
    Neuropathol Appl Neurobiol; 2001 Feb 30; 27(1):68-76. PubMed ID: 11299004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.